Agrimin Limited (ASX:AMN) Initiates Strategic Review and Announces Executive Changes
Agrimin Limited (ASX:AMN) begins a strategic review of its Mackay Potash Project and announces CEO resignation alongside COO promotion.
ikeGPS Group Limited (ASX:IKE) Rejects Acquisition Offer
ikeGPS Group Limited (ASX:IKE) rejects a 62% premium acquisition offer, continuing to focus on growth strategy and strong operational performance.
Atlas Arteria (ASX:ALX) Announces New French Temporary Supplemental Tax
Atlas Arteria (ASX:ALX) outlines the impact of France’s new temporary supplemental tax on its financial obligations.
Charter Hall Long WALE REIT (ASX:CLW) Announces 2025 Half Year Results
Charter Hall Long WALE REIT (ASX:CLW) reports strong financial performance and strategic portfolio updates in its 2025 half year results.
Domino’s Pizza Enterprises Limited (ASX:DMP) Announces H1 2025 Trading Update
Domino’s Pizza Enterprises Limited (ASX:DMP) announces its H1 2025 trading update, detailing store closures, financial performance, and dividend plans.
Charter Hall Long WALE REIT (ASX:CLW) Publishes 2025 Half Year Results
Charter Hall Long WALE REIT (ASX:CLW) announces its 2025 half-year results, highlighting stable financial performance and strategic portfolio developments.
Shekel Brainweigh Ltd (ASX:SBW) Suspended from Quotation
Shekel Brainweigh Ltd (ASX:SBW) has suspended its securities from ASX quotation pending removal from the official list.
Eumundi Group Limited (ASX:EBG) Takeover Offer by SEQ Hospitality Withdrawn
SEQ Hospitality withdraws its off-market takeover bid for Eumundi Group Limited (ASX:EBG), following scheme approval.
ReNu Energy Limited (ASX:RNE) Announces Sale of Countrywide Hydrogen Business
ReNu Energy Limited (ASX:RNE) is set to sell its Countrywide Hydrogen Business, including a Tasmanian green hydrogen project, pending shareholder approval.
Actinogen Medical (ASX:ACW) Publishes Clinical Pharmacology Study on Xanamem
Actinogen Medical (ASX:ACW) publishes study validating the 10 mg dose of Xanamem for CNS disease treatment, supporting ongoing clinical trials.